| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0013700 | Exon-Exon | chr10:31662051-31676195 | chr10:31373122-31387266 | 250 nt | 0.3240 |
| hsa_ZEB1_0000500 | Exon-Exon | chr10:31607424-31676195 | chr10:31318495-31387266 | 250 nt | 0.4480 |
| hsa_ZEB1_0000600 | Exon-Exon | chr10:31607842-31676195 | chr10:31318913-31387266 | 250 nt | 0.4240 |
| hsa_ZEB1_0001200 | Exon-Exon | chr10:31610064-31676195 | chr10:31321135-31387266 | 250 nt | 0.3680 |
| hsa_ZEB1_0001300 | Intron-Intron | chr10:31612066-31612502 | chr10:31323137-31323573 | 437 nt | 0.3021 |
| hsa_ZEB1_0005300 | Intron-Exon-Intron | chr10:31644073-31647262 | chr10:31355144-31358333 | 250 nt | 0.3440 |
| hsa_ZEB1_0005900 | Intron-Exon-Intron | chr10:31644073-31676195 | chr10:31355144-31387266 | 250 nt | 0.3480 |
| hsa_ZEB1_0006000 | Intron-Exon-Intron | chr10:31644073-31676727 | chr10:31355144-31387798 | 250 nt | 0.3040 |
| hsa_ZEB1_0006800 | Intron-Exon-Intron | chr10:31644073-31750166 | chr10:31355144-31461237 | 250 nt | 0.3720 |
| hsa_ZEB1_0007300 | Exon-Intron | chr10:31644076-31647262 | chr10:31355147-31358333 | 250 nt | 0.3440 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].